China SXT Pharmaceuticals, Inc. current report, Q3 FY2019

Business Context and Reporting Period

This Form 6-K filing by China SXT Pharmaceuticals, Inc. covers the month of July 2019. The report details significant developments regarding a private placement of senior convertible notes completed in May 2019 and subsequent events of default declared by investors in July 2019.

Key Financial Metrics and Debt Obligations

The filing does not provide standard financial metrics such as revenue, profit, cash flow, or operating margins. The primary financial data relates to debt obligations and redemption demands:

  • Total Private Placement Principal: $15 million (Series A: $10 million; Series B: $5 million).
  • Consideration Received: $10 million cash and $5 million in investor promissory notes.
  • Alto Redemption Demand: $6,055,410.15 (Principal, interest, make-whole, and late charges on Series A Notes).
  • Hudson Bay Redemption Demand: $8,263,052.47 (Event of Default Redemption Price on Series A Notes).
  • Hudson Bay Additional Demands: $222,698.10 (Liquidated damages/late charges) and purchase of Series A Warrants valued at not less than $1,208,384.07.

Material Changes and Events of Default

Two investors issued Event of Default Redemption Notices in July 2019:

  • Alto B Opportunity Master Fund (July 23, 2019): Claimed failure to make an installment payment due on July 19, 2019. They elected to redeem the entire Series A Note principal plus accrued amounts.
  • Hudson Bay Master Fund (July 29, 2019): Alleged failure to timely deliver shares for a conversion notice dated July 10, 2019. They demanded redemption of Series A Notes and the purchase of associated warrants. Hudson Bay reserved the right to demand redemption of Series B Notes in the future.

Outlook, Risks, and Management Commentary

Management states the Company is currently in negotiation with the investors to obtain a forbearance and release agreement. The filing includes a standard disclaimer regarding forward-looking statements, noting that actual results may differ materially from expectations due to risks and uncertainties. No specific financial guidance or operational outlook was provided in this report.

Investor Verification Checklist

  • Verify the current status of negotiations for the forbearance and release agreement with Alto and Hudson Bay.
  • Confirm whether the Company has secured additional liquidity to meet the combined redemption demands exceeding $15 million.
  • Monitor for any further notices regarding the Series B Notes, as Hudson Bay reserved rights to demand their redemption.
  • Check for subsequent filings detailing the resolution of the default events or potential restructuring of the debt.